JP2025500176A5 - - Google Patents
Info
- Publication number
- JP2025500176A5 JP2025500176A5 JP2024535200A JP2024535200A JP2025500176A5 JP 2025500176 A5 JP2025500176 A5 JP 2025500176A5 JP 2024535200 A JP2024535200 A JP 2024535200A JP 2024535200 A JP2024535200 A JP 2024535200A JP 2025500176 A5 JP2025500176 A5 JP 2025500176A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217534 | 2021-12-23 | ||
| EP21217534.3 | 2021-12-23 | ||
| EP22201158 | 2022-10-12 | ||
| EP22201158.7 | 2022-10-12 | ||
| PCT/EP2022/087752 WO2023118576A1 (en) | 2021-12-23 | 2022-12-23 | Dhodh inhibitors containing a carboxylic acid bioisostere |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500176A JP2025500176A (ja) | 2025-01-09 |
| JP2025500176A5 true JP2025500176A5 (https=) | 2026-01-06 |
| JPWO2023118576A5 JPWO2023118576A5 (https=) | 2026-01-06 |
Family
ID=84981773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535200A Pending JP2025500176A (ja) | 2021-12-23 | 2022-12-23 | カルボン酸バイオアイソスタを含むｄｈｏｄｈ阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250066290A1 (https=) |
| EP (1) | EP4452929A1 (https=) |
| JP (1) | JP2025500176A (https=) |
| KR (1) | KR20240130096A (https=) |
| AR (1) | AR128080A1 (https=) |
| AU (1) | AU2022422334B2 (https=) |
| CA (1) | CA3240950A1 (https=) |
| IL (1) | IL313501A (https=) |
| MX (1) | MX2024007336A (https=) |
| PY (1) | PY22111032A (https=) |
| TW (1) | TW202332433A (https=) |
| UY (1) | UY40087A (https=) |
| WO (1) | WO2023118576A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202444688A (zh) | 2023-03-29 | 2024-11-16 | 德商埃慕尼克股份公司 | 作為nurr1激動劑之維多氟地莫(vidofludimus)及相關結構 |
| TW202506107A (zh) | 2023-06-28 | 2025-02-16 | 德商埃慕尼克股份公司 | 雜芳族dhodh抑制劑 |
| WO2026074007A1 (en) | 2024-10-02 | 2026-04-09 | Immunic Ag | Nurr1 agonists with replacement of the carboxylic acid or carboxamide moiety for use in the treatment of neurodegenerative diseases |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| US7071355B2 (en) | 2002-12-23 | 2006-07-04 | 4 Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| EP1581478A1 (en) | 2002-12-23 | 2005-10-05 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| MXPA05006890A (es) | 2002-12-23 | 2006-04-07 | 4Sc Ag | Compuestos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. |
| CN102271674A (zh) | 2008-11-07 | 2011-12-07 | 4Sc股份公司 | 用于治疗自身免疫病的包含dhodh抑制剂和氨甲喋呤的联合治疗 |
| TWI530286B (zh) * | 2009-05-04 | 2016-04-21 | 帕納特斯製藥格斯有限公司 | 作為抑制病毒化合物之抗發炎劑 |
| UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
| JP2016034901A (ja) | 2012-11-26 | 2016-03-17 | 中外製薬株式会社 | ３，４−ジフルオロ−２−（２−フルオロ−４−ヨード−フェニルアミノ）−ｎ−（２−ヒドロキシ−エトキシ）−５−（３−オキソ−［１，２］オキサジナン−２−イルメチル）−ベンズアミドの新規結晶形 |
| KR102265277B1 (ko) | 2014-04-11 | 2021-06-16 | 판옵테스 파르마 게스.엠.베.하. | 바이러스 억제 화합물로서의 항-염증제 |
| PL3139914T3 (pl) | 2014-05-08 | 2023-11-27 | Kiora Pharmaceuticals Gmbh | Związki stosowane w leczeniu chorób i schorzeń okulistycznych |
| WO2018177151A1 (en) | 2017-03-28 | 2018-10-04 | Xiamen University | Compounds modulating activity of farnesoid x receptor and methods for the use thereof |
| CN111343975A (zh) | 2017-11-23 | 2020-06-26 | 埃慕尼克股份公司 | 用于预防或治疗慢性炎性疾病和/或自身免疫疾病的维多地莫的剂量方案 |
| JP6804790B1 (ja) | 2017-12-07 | 2020-12-23 | エモリー ユニバーシティー | Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 |
| ES2972099T3 (es) | 2018-03-09 | 2024-06-11 | Kiora Pharmaceuticals Gmbh | Formulación oftálmica |
| WO2019175396A1 (en) | 2018-03-16 | 2019-09-19 | Immunic Ag | Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
-
2022
- 2022-12-22 UY UY0001040087A patent/UY40087A/es unknown
- 2022-12-23 US US18/719,384 patent/US20250066290A1/en active Pending
- 2022-12-23 TW TW111149720A patent/TW202332433A/zh unknown
- 2022-12-23 PY PY202222111032A patent/PY22111032A/es unknown
- 2022-12-23 AR ARP220103564A patent/AR128080A1/es unknown
- 2022-12-23 WO PCT/EP2022/087752 patent/WO2023118576A1/en not_active Ceased
- 2022-12-23 CA CA3240950A patent/CA3240950A1/en active Pending
- 2022-12-23 KR KR1020247022694A patent/KR20240130096A/ko active Pending
- 2022-12-23 AU AU2022422334A patent/AU2022422334B2/en active Active
- 2022-12-23 JP JP2024535200A patent/JP2025500176A/ja active Pending
- 2022-12-23 EP EP22844140.8A patent/EP4452929A1/en active Pending
- 2022-12-23 MX MX2024007336A patent/MX2024007336A/es unknown
- 2022-12-23 IL IL313501A patent/IL313501A/en unknown